Neurology · 1999 · 29 citations · 7 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyMolecular VirologyVirologyImmunopathology Of Infectious DiseasesViral InfectionsViral PathologyCerebrospinal Fluid Mononuclear CellsCorrelationDisease Progression PredictionDisease Progression SubtypingViral Load AssaysViral Load Assessment
The authors measured human T-cell lymphotrophic virus type I (HTLV-I) proviral load and intrathecal synthesis of antibodies to HTLV-I in CSF of 13 Brazilian patients with tropical spastic paraparesis/ HTLV-I-associated myelopathy (HAM). The authors also measured HTLV-I proviral load in peripheral blood mononuclear cells of five of these patients and found that it was 10- to 100-fold higher than that in CSF cells. The combination of HTLV-I proviral load and intrathecal synthesis of antibodies to HTLV-I appears to be a useful marker of disease progression. Patients with high viral load and no intrathecal synthesis of antibodies to HTLV-I had more rapidly progressing, serious clinical disease.
7
High Levels of HIV-1 in Plasma During All Stages of Infection Determined By Competitive PCR
M. Piatak, M. S. Saag, Linghui Yang et al. · Science · 1993 · 1.2K citations
Intensive Immunosuppression in Progressive Multiple Sclerosis
Stephen L. Hauser, David M. Dawson, James R. Lehrich et al. · New England Journal of Medicine · 1983 · 826 citations
Pharmacy, Neurology, Pharmacotherapy +14
Masahiro Nagai, Koichiro Usuku, Wataru Matsumoto et al. · Journal of NeuroVirology · 1998 · 698 citations